Abstract Purpose of Review The purpose of this update is to summarize the recent advances
on the management of cerebral venous thrombosis (CVT). Recent Findings There is a trend …

Objectives Current guidelines do not recommend direct oral anticoagulants (DOACs) to treat
cerebral venous thrombosis (CVT) despite their benefits over standard therapy. We …

Background: A small randomized controlled trial suggested that dabigatran may be as
effective as warfarin in the treatment of cerebral venous thrombosis (CVT). We aimed to …

Background and Purpose—The hypothesis that venous recanalization prevents progression
of venous infarction is not established in patients with cerebral venous thrombosis (CVT) …

Abstract Purpose of Review Cerebral venous thrombosis (CVT) is a rare cause of stroke that
most commonly affects younger women. Here, we review new literature relevant to the …

The burden of poorer outcomes in the published literature is generally borne by those
outside this demographic. Older age, male sex, and CVT occurring outside the context of the …

Background Recanalization in cerebral venous thrombosis (CVT) can begin as early as one
week after initiating therapeutic anticoagulation. The clinical significance of recanalization …

Cerebral venous thrombosis (CVT) has an incidence of 1.32/100,000/years in high-income
countries, and higher in middle-and low-income countries. CVT is more frequent in infants …

Cerebral vein thrombosis (CVT) and splanchnic vein thrombosis (SVT) are two
manifestations of venous thromboembolism (VTE) at unusual sites. They have an incidence …

Background The effect of different anticoagulants on recanalization after cerebral venous
thrombosis has not been studied in a randomized controlled trial. Methods RE-SPECT CVT …